ADDvise Group

ADDvise Group AB (publ) ("ADDvise" or the "Company") has mandated Pareto Securities AB and Skandinaviska Enskilda Banken AB (publ) to arrange a series of credit investor meetings commencing on 18 March 2024. To better align the Company's long-term funding with its operational currency exposure, the Company considers, subject to inter alia market conditions, the issuance of a new 3-year senior secured bond in an amount of approximately USD 60 million ("New Bonds") coupled with a partial buy-back offer in its outstanding bond (ISIN: SE0020180271) ("SEK Bonds") of up to SEK 450 million (the "Buy-Back").

Any excess proceeds from the New Bonds shall be used to finance general corporate purposes (including capital expenditures and acquisitions).

The purchase price for the Buy-Back will be determined by way of a bookbuilding process and will be the same for all investors participating in the Buy-Back. Holders of SEK Bonds participating in the issuance of New Bonds will be offered priority in the Buy-Back allocation. Investors interested in participating in the Buy-Back should contact Pareto Securities via the contact details below.

For further information, please contact:

Pareto Securities:

Caroline Nytvedt

DCM Syndicate

+47 22 87 88 17

caroline.nytvedt@paretosec.com

ADDvise:

Rikard Akhtarzand, CEO
+46 (0)76-525 90 71
rikard.akhtarzand@addvisegroup.se

Oliver Humlen, CFO
+46 (0)70-916 26 97
oliver.humlen@addvisegroup.se

About ADDvise

ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

This information is such that ADDvise Group AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons above, on March 18, 2024, at 07:45 CET.